Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$8.70 +0.02 (+0.23%)
(As of 12/20/2024 05:51 PM ET)

Recent Novavax SEC Filings

DateFilerForm TypeView
12/18/2024
4:24 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:24 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
11:13 AM
King Rachel K. (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
5:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:06 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:37 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
5:16 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/20/2024
4:08 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:35 PM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G/A
06/06/2024
6:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:35 PM
Novavax (Filer)
Form DEFA14A
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
03/26/2024
6:00 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:00 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:01 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:02 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:03 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Combine the QQQ, IWM and SPY in one trade (Ad)

If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…

You can find out about this “2-Click Trade” here.
03/26/2024
5:11 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:45 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:39 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:30 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:30 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:02 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
12:59 PM
MORGAN STANLEY (Filed by)
Novavax (Subject)
Form SC 13G
01/31/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
7:57 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:25 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners